EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Role of the AT-Rich Interaction Domain 1A Gene (ARID1A) in Human Carcinogenesis

Jing Jing Li, Cheok Soon Lee

Genes · 19.12.2023 · 15 (1) · 5

DOI: 10.3390/genes15010005 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Genes, online erschienen am 19.12.2023. Verfasst von Jing Jing Li und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomical Pathology, Liverpool Hospital, Liverpool, NSW 2170, Australia. Hauptthemen laut MEDLINE: Nuclear Proteins, Ovarian Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 145 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Royal College of Pathologists of Australasia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The switch/sucrose non-fermentable (SWI/SNF) (SWI/SNF) complex uses energy from ATP hydrolysis to mobilise nucleosomes on chromatin. Components of SWI/SNF are mutated in 20% of all human cancers, of which mutations in AT-rich binding domain protein 1A (ARID1A) are the most common. ARID1A is mutated in nearly half of ovarian clear cell carcinoma and around one-third of endometrial and ovarian carcinomas of the endometrioid type. This review will examine in detail the molecular functions of ARID1A, including its role in cell cycle control, enhancer regulation, and the prevention of telomerase activity. ARID1A has key roles in the maintenance of genomic integrity, including DNA double-stranded break repair, DNA decatenation, integrity of the cohesin complex, and reduction in replication stress, and is also involved in mismatch repair. The role of ARID1A loss in the pathogenesis of some of the most common human cancers is discussed, with a particular emphasis on gynaecological cancers. Finally, several promising synthetic lethal strategies, which exploit the specific vulnerabilities of ARID1A-deficient cancer cells, are briefly mentioned.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nuclear ProteinsOvarian NeoplasmsFemaleHumansMutationCarcinogenesisDNADNA-Binding ProteinsTranscription Factors

Stichwörter der Autor:innen

ARID1ABAFSWI/SNFcancersynthetic lethalitytumour suppressor

Substanzen

Nuclear ProteinsDNAARID1A protein, humanDNA-Binding ProteinsTranscription Factors

Autor:innen und Institutionen

  • Department of Anatomical Pathology, Liverpool Hospital, Liverpool, NSW 2170, Australia.
  • Ingham Institute for Applied Medical Research, Liverpool, NSW 2170, Australia.
  • Discipline of Pathology, School of Medicine, Western Sydney University, Sydney, NSW 2560, Australia.
  • South Western Sydney Clinical School, University of New South Wales, Liverpool, NSW 2170, Australia.
  • Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW 2010, Australia.

Förderung

  • Royal College of Pathologists of Australasia

Zitieren

APA

Li, J. J., & Lee, C. S. (2023). The Role of the AT-Rich Interaction Domain 1A Gene (ARID1A) in Human Carcinogenesis. Genes, 15(1), 5. https://doi.org/10.3390/genes15010005

Vancouver

Li JJ, Lee CS. The Role of the AT-Rich Interaction Domain 1A Gene (ARID1A) in Human Carcinogenesis. Genes. 2023;15(1):5. doi:10.3390/genes15010005

BibTeX
@article{Li2023,
  author = {Li, Jing Jing and Lee, Cheok Soon},
  title = {The Role of the AT-Rich Interaction Domain 1A Gene (ARID1A) in Human Carcinogenesis},
  journal = {Genes},
  year = {2023},
  volume = {15},
  number = {1},
  pages = {5},
  doi = {10.3390/genes15010005}
}
Kostenlos starten →